KPV 30mg — Vial Spec, Reconstitution Math & COA

Vial Specifications and High-Yield Format Analysis

The 30mg KPV (Lysine-Proline-Valine) vial configuration provides an elevated mass concentration tailored for academic and industrial laboratories conducting large-scale preclinical studies. In experimental models requiring daily dosing across multiple rodent cohorts or repeated cellular assays across multiple cell lines, higher mass yields reduce container-to-container variability and streamline stock solution preparation.

Each 30mg unit is packaged as a lyophilized, sterile cake within a USP Type I borosilicate glass vial, sealed with a chlorobutyl rubber stopper and an aluminum flip-off cap. This packaging ensures structural integrity and protects the peptide matrix against moisture infiltration and oxidative degradation during cold-chain transport and long-term storage.

High-density configurations such as the 30mg format are predominantly specified by high-volume screening facilities, core research units, and investigators executing multi-week rodent colitis or gut barrier functional studies where consistent, batch-matched stock concentrations are essential for valid longitudinal comparative data.

Molecular Identity and Preclinical Mechanism of KPV

KPV is a C-terminal tripeptide fragment (Lys-Pro-Val) derived from alpha-melanocyte-stimulating hormone (alpha-MSH). Unlike its parent molecule, KPV demonstrates potent anti-inflammatory properties without activating melanocortin receptors responsible for pigmentary responses, making it an isolated subject of study for targeted signaling pathways. Preclinical studies suggest that KPV exerts its primary biochemical effects by translocating across plasma membranes and modulating intracellular signaling cascades, particularly the nuclear factor kappa B (NF-kB) signaling pathway.

In vitro data indicate that KPV enters intestinal epithelial cells via the solute carrier transporter PepT1 (SLC15A1), which is frequently upregulated in inflamed intestinal tissues. Once intracellular, the tripeptide inhibits the phosphorylation and degradation of IkB-alpha, thereby suppressing NF-kB nuclear translocation and downregulating downstream pro-inflammatory cytokines such as TNF-alpha, IL-6, and IL-1-beta.

Animal study models, specifically murine models of dextran sulfate sodium (DSS)-induced colitis, demonstrate that localized delivery of KPV attenuates histological mucosal damage, preserves tight junction integrity (including ZO-1 and Occludin expression), and reduces inflammatory cell infiltration into the lamina propria. For broader context on melanocortin-derived fragments and signaling pathways, researchers can review our expanded research library hub and alpha-MSH peptide literature.

Reconstitution Mathematics for a 30mg Lyophilized Cake

Reconstitution of a 30mg lyophilized cake requires precise volumetric calculation to establish target working concentrations for laboratory assays. Depending on the assay dynamic range, researchers typically select Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline (0.9% NaCl) as the reconstitution vehicle.

To achieve target stock concentrations using a 30mg mass balance, the following volumetric diluent additions apply: Adding 1.0 mL of diluent yields a final concentration of 30.0 mg/mL (30.0 µg/µL). Adding 2.0 mL of diluent yields a final concentration of 15.0 mg/mL (15.0 µg/µL). Adding 3.0 mL of diluent yields a final concentration of 10.0 mg/mL (10.0 µg/µL).

To calculate custom concentration volumes for specific assay microplates or animal administration volumes, scientists can utilize our interactive reconstitution calculator tool. When adding liquid to a 30mg vial, direct the stream along the internal glass wall rather than directly onto the lyophilized plug to prevent foaming and shear stress on the peptide bonds.

Aliquot Planning and Degradation Prevention

Repeated freeze-thaw cycles significantly accelerate peptide cleavage and aggregation. Once a 30mg KPV vial is reconstituted into a liquid phase, establishing a strict sub-aliquoting protocol is vital to maintain molecular stability over extended experimental timelines.

Following total dissolution, stock solutions should be divided into single-use microcentrifuge tubes (preferably low-binding polypropylene) calibrated to the specific daily volume needed for cell culture additions or animal dosing assays. For instance, a 3.0 mL stock solution at 10 mg/mL can be divided into thirty 100 µL aliquots (containing 1.0 mg KPV per tube).

Aliquots should be stored at -20°C or -80°C depending on the scheduled length of the trial. Once an aliquot is thawed for an experimental run, any unused portion should be stored at 2°C to 8°C and consumed within 24 to 48 hours, or discarded to prevent degradation and loss of activity.

Comparing Fill Sizes: 10mg vs 30mg Configurations

Selecting between different fill sizes depends on experimental design, throughput requirements, and storage capabilities. Smaller fill sizes reduce the risks associated with multi-dose liquid degradation, whereas larger formats reduce container variability across extensive trial cohorts.

A 10mg format is typically selected for pilot studies, dose-response assay development, or shorter treatment windows where fresh reconstituted stock is required frequently. Conversely, a 30mg format is ideal for ongoing, multi-animal in vivo studies or continuous cell culture models requiring consistent baseline stock over several weeks.

Please note: If PX1 Research does not currently list an active 30mg stock unit on the primary platform, investigators are encouraged to source our standard, highly pure KPV 10mg vials or browse our comprehensive research peptides catalog to meet their laboratory capacity needs.

Quality Control, HPLC/MS, and Lot-Matched COA Verification

PX1 Research enforces stringent analytical testing protocols for every manufactured production run. Chemical identity and purity verification are non-negotiable standards for reproducible preclinical research.

Each lot undergoes High-Performance Liquid Chromatography (HPLC) to establish chemical purity (consistently exceeding 98.0%) and Mass Spectrometry (MS) to verify molecular weight against the theoretical mass of Lys-Pro-Val (342.44 g/mol). Furthermore, materials undergo chromogenic LAL assay testing to verify that bacterial endotoxin levels remain strictly under <0.1 EU/mg, minimizing non-specific inflammatory responses in cellular assays.

Every shipped order includes a direct, lot-matched Certificate of Analysis. Laboratory personnel can independently verify batch data, analytical spectra, and purity testing parameters by reviewing our online COA database.

Comparative Analysis: Preclinical Anti-Inflammatory Compounds

When designing protocols to investigate intestinal barrier mechanics, tissue repair, or mucosal inflammation, research groups frequently compare KPV against other targeted peptide candidates. In addition to melanocortin derivatives like KPV, the synthetic pentadecapeptide BPC-157 5mg is extensively studied in rodent models for its gastroprotective, angiogenic, and extracellular matrix remodeling capabilities. Similarly, tight junction modulators like Larazotide are routinely evaluated for their ability to block zonulin-mediated intestinal permeability, while neuroendocrine agents such as VIP are evaluated for immunomodulatory regulation within the gut-associated lymphoid tissue (GALT).

While KPV targets nuclear NF-kB translocation via intracellular PepT1 transport, BPC-157 acts primarily through VEGFR2 and FAK pathway modulation, and Larazotide targets apical junctional complexes directly. Evaluating these distinct mechanistic pathways allows researchers to select individual compounds or dual-target experimental models depending on the specific mucosal pathology under investigation.

In Vitro and Preclinical Assay Protocols

In cell culture experiments utilizing Caco-2, HT-29, or IEC-6 intestinal epithelial monolayers, reconstituted KPV is typically diluted into serum-free culture medium prior to cellular exposure. Preclinical studies suggest working concentrations between 10 nM and 100 µM depending on whether the assay measures cell migration, cytokine downregulation, or transepithelial electrical resistance (TEER).

Vehicle controls should always be maintained. When using Bacteriostatic Water containing benzyl alcohol, final culture dilutions must reduce the vehicle concentration to non-toxic levels (<0.01% v/v) to avoid solvent-induced cytotoxicity.

For animal model applications (e.g., murine colitis models), reconstituted stock is typically diluted into sterile 0.9% saline. Preclinical literature reports administration via oral gavage, intraperitoneal injection, or localized intracolonic instillation to evaluate regional versus systemic anti-inflammatory distribution.

Storage Stability and Handling Guidelines

Lyophilized KPV powder exhibits robust stability when stored in dark, temperature-controlled conditions. Unopened vials stored at -20°C remain stable for up to 24 months. For short-term storage during active testing protocols, desiccated lyophilized vials may be held at 2°C to 8°C for up to 90 days without measurable degradation.

Upon reconstitution, liquid stock solutions stored at 2°C to 8°C should be used within 7 to 14 days if prepared with Bacteriostatic Water. If reconstituted with unpreserved sterile saline, the solution must be used immediately or frozen into sub-aliquots at -80°C to prevent microbial growth and hydrolytic cleavage.

Exposure to direct ultraviolet light, ambient heat above 25°C, and rapid mechanical agitation (vortexing) must be avoided to prevent denaturation of the peptide structure.

Sourcing and Procurement via Institutional Accounts

PX1 Research supplies high-purity research compounds strictly to verified academic institutions, biotechnology firms, and contract research organizations (CROs). All manufacturing is conducted in GMP-compliant, ISO 17025 certified facilities based in the United States.

Orders placed before cutoff times ship same-day from our distribution centers located in California and Arizona, ensuring minimal transit times and maintained cold-chain integrity. For high-volume institutional orders or recurring protocol requirements, laboratories can register for dedicated corporate pricing via our wholesale research portal.